Date:04-May-2024  Time: 10:35 AM

Company Profile Get Quotes Background Board of Directors Balance Sheet Profit & Loss  Quarterly Results Financial Ratios Share Price Charts          Astrazeneca Pharma India Ltd Quarters:       3 4 5 6 (Rs. In Crores) Particulars Dec 2023 Sep 2023 Jun 2023 Mar 2023 Type 3Qtr 2Qtr 1Qtr 4Qtr Net Sales 305.79 311.07 295.46 284.70 Other Income 9.66 24.80 8.10 8.00 Total Income 315.45 335.87 303.56 292.70 Total Expenditure 290.73 258.31 228.21 265.08 Operating Profit 24.72 77.56 75.35 27.62 Interest 0.61 0.50 0.15 0.09 Gross Profit 24.10 77.06 75.20 27.53 Depreciation 3.70 3.67 3.80 4.25 Tax 4.65 21.29 17.47 8.38 Deferred Tax -0.06 -0.28 0.07 -2.37 Reported Profit After Tax 15.80 52.37 53.86 17.27 Source:Capital Market

Useful linksNSEIBSEI SEBIINSDLI NCDEXI CDSLIRBI      Careers | Feedback | Sitemap | Disclaimer | Privacy Policy | Grievances Sebi Reg No: NSE INB231168734(CM) INF231168734(F&O) Sebi Reg No: BSE INB011168730 INF011168730   NCDEX: Membership Code: 00774 MCX: Membership Code: 31560  Mutual Funds: ARN0843. FMC Unique Membership Code: MCX/TCM/CORP/1106 2006-07 © Senator Securities Pvt. Ltd. All rights reserved FMC Unique Membership Code: NCDEX/TCM/CORP/0760 Design, developed & maintained by C-MOTS Infotech(ISO 9001:2000 certified) Content powered by capitalmarket.com